NEW: FDA's Julie Tierney and Dr. Nicole Verdun to Speak at ASGCT's Policy Summit (Sept. 23-24). Register Now!
February 16, 2022 | 1:00-3:00 p.m. (CT)
During this session, speakers will discuss cutting-edge concepts and methods in the design and development of AAV vectors. Individual presentations will be followed by a panel discussion where the invited experts will be available to answer questions from attendees and opine about personal experience and perspectives in the field.
Registrants & ASGCT Members: Watch on demand!
Phillip Tai, PhD University of Massachusetts Medical School
Joseph Rabinowitz Kriya Therapeutics
Beverly Davidson, PhD Children's Hospital of Philadelphia
Miguel Sena-Esteves, PhD University of Massachusetts Medical School
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico